RS&UT; exemption for prescription medicine and drugs purchased by veterinarians, extends sunset.
Summary
SB 1369 amends Virginia’s retail sales and use tax exemption statute to extend a narrow exemption for prescription medicines and drugs purchased by veterinarians. Under the bill, the existing exemption for veterinarian-purchased prescription medicines and drugs, which was scheduled to sunset on July 1, 2025, is extended through July 1, 2028. The exemption applies only when the medicines or drugs are administered or dispensed to patients within a veterinarian-client-patient relationship as defined in Virginia law.
The bill does not create a new tax exemption category; rather, it preserves an existing one for an additional three years. In practical terms, veterinarians purchasing qualifying prescription medicines and drugs for animal patients will continue to avoid state retail sales and use tax on those purchases during the extended period. The change affects the administration of Virginia Code § 58.1-609.10, which lists miscellaneous sales tax exemptions, and it may modestly reduce tax collections associated with veterinary practices while lowering input costs for animal health care providers.
The legislative record shows strong and consistent support for the measure. It passed the Senate and House overwhelmingly, including unanimous committee action and near-unanimous floor votes, and the final conference report was agreed to by both chambers without recorded opposition. The absence of committee testimony in the available record suggests there was little public controversy or debate surrounding the bill.
There is no notable recorded contention in the voting history. The only apparent issue was procedural rather than substantive: the House adopted a substitute version, which the Senate initially rejected before the chambers resolved the differences in conference. That indicates some drafting or technical disagreement, but not opposition to the underlying policy of extending the exemption.
Overall, SB 1369 is a targeted tax-relief measure for veterinary medicine, extending an existing sales and use tax exemption for prescription drugs used in animal care. Its impact is limited to the sunset date in the exemption statute, and the bill was broadly viewed as noncontroversial and routine.
Impact
The bill amends Virginia Code § 58.1-609.10 to extend the sunset date for the sales and use tax exemption on prescription medicines and drugs purchased by veterinarians from July 1, 2025 to July 1, 2028. This preserves tax-free treatment for qualifying veterinary drug purchases made within a veterinarian-client-patient relationship, affecting veterinary practices, animal patients, and state tax administration. It may slightly reduce state and local sales tax revenue associated with those purchases while maintaining an existing cost-saving exemption for the veterinary sector.
Sentiment
The overall sentiment around SB 1369 was strongly positive and largely procedural. The bill moved through committee and both chambers with overwhelming bipartisan support, including unanimous or near-unanimous votes and no recorded dissent in the final conference report. The available record suggests the measure was viewed as a routine extension of an existing exemption rather than a controversial policy change.
Contention
There was little substantive contention over the bill. The only visible disagreement was procedural: the House passed a substitute version, and the Senate initially rejected that substitute before the chambers resolved the differences in conference. No committee transcripts are available, and the vote history shows no recorded opposition to the underlying extension of the veterinary prescription drug tax exemption.